Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:
Net Sales at Rs 48.09 crore in March 2019 down 28.43% from Rs. 67.19 crore in March 2018.
Story continues below Advertisement
Quarterly Net Loss at Rs. 6.01 crore in March 2019 down 296.61% from Rs. 3.06 crore in March 2018.
EBITDA stands at Rs. 0.47 crore in March 2019 down 95.11% from Rs. 9.62 crore in March 2018.
Mangalam Drugs shares closed at 48.50 on May 10, 2019 (NSE) and has given -41.53% returns over the last 6 months and -69.94% over the last 12 months.
Story continues below Advertisement
| Mangalam Drugs & Organics | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'19 | Dec'18 | Mar'18 | | Net Sales/Income from operations | 48.09 | 48.58 | 67.20 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 48.09 | 48.58 | 67.20 | | EXPENDITURE | | Consumption of Raw Materials | 37.37 | 39.51 | 40.45 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -1.82 | -7.84 | 0.19 | | Power & Fuel | -- | -- | -- | | Employees Cost | 6.48 | 6.37 | 5.97 | | Depreciation | 1.66 | 1.83 | 2.58 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 5.79 | 11.54 | 11.08 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.39 | -2.83 | 6.93 | | Other Income | 0.21 | 0.05 | 0.10 | | P/L Before Int., Excpt. Items & Tax | -1.19 | -2.78 | 7.04 | | Interest | 2.53 | 2.30 | 3.43 | | P/L Before Exceptional Items & Tax | -3.71 | -5.08 | 3.61 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -3.71 | -5.08 | 3.61 | | Tax | 2.29 | -0.66 | 0.55 | | P/L After Tax from Ordinary Activities | -6.01 | -4.42 | 3.06 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -6.01 | -4.42 | 3.06 | | Equity Share Capital | 15.83 | 15.83 | 15.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.80 | -2.79 | 1.93 | | Diluted EPS | -3.80 | -2.79 | 1.93 | | EPS After Extra Ordinary | | Basic EPS | -3.80 | -2.79 | 1.93 | | Diluted EPS | -3.80 | -2.79 | 1.93 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
